Unraveling the relationship between histone methylation and nonalcoholic fatty liver disease
- PMID: 38818286
- PMCID: PMC11135277
- DOI: 10.4254/wjh.v16.i5.703
Unraveling the relationship between histone methylation and nonalcoholic fatty liver disease
Abstract
Non-alcoholic fatty liver disease (NAFLD) poses a significant health challenge in modern societies due to shifts in lifestyle and dietary habits. Its complexity stems from genetic predisposition, environmental influences, and metabolic factors. Epigenetic processes govern various cellular functions such as transcription, chromatin structure, and cell division. In NAFLD, these epigenetic tendencies, especially the process of histone methylation, are intricately intertwined with fat accumulation in the liver. Histone methylation is regulated by different enzymes like methyltransferases and demethylases and influences the expression of genes related to adipogenesis. While early-stage NAFLD is reversible, its progression to severe stages becomes almost irreversible. Therefore, early detection and intervention in NAFLD are crucial, and understanding the precise role of histone methylation in the early stages of NAFLD could be vital in halting or potentially reversing the progression of this disease.
Keywords: Adipogenesis; Demethytrasferases; Epigenetic modification; Histone methylation; Mechanism; Methyltransferases; Non-alcoholic fatty liver disease.
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Conflict of interest statement
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Similar articles
-
Histone Methylation Regulation as a Potential Target for Non-alcoholic Fatty Liver Disease.Curr Protein Pept Sci. 2023;24(6):465-476. doi: 10.2174/1389203724666230526155643. Curr Protein Pept Sci. 2023. PMID: 37246318 Review.
-
Targeting histone methylation and demethylation for non-alcoholic fatty liver disease.Bioorg Chem. 2024 Oct;151:107698. doi: 10.1016/j.bioorg.2024.107698. Epub 2024 Aug 6. Bioorg Chem. 2024. PMID: 39126869 Review.
-
Epigenetic association study uncovered H3K27 acetylation enhancers and dysregulated genes in high-fat-diet-induced nonalcoholic fatty liver disease in rats.Epigenomics. 2022 Dec;14(23):1523-1540. doi: 10.2217/epi-2022-0362. Epub 2023 Feb 22. Epigenomics. 2022. PMID: 36851897
-
Genetic and epigenetic variants influencing the development of nonalcoholic fatty liver disease.World J Gastroenterol. 2012 Dec 7;18(45):6546-51. doi: 10.3748/wjg.v18.i45.6546. World J Gastroenterol. 2012. PMID: 23236228 Free PMC article. Review.
-
Epigenetic Regulation in Lean Nonalcoholic Fatty Liver Disease.Int J Mol Sci. 2023 Aug 16;24(16):12864. doi: 10.3390/ijms241612864. Int J Mol Sci. 2023. PMID: 37629043 Free PMC article. Review.
References
-
- Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, Harrison SA, Brunt EM, Sanyal AJ. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018;67:328–357. - PubMed
-
- Podrini C, Borghesan M, Greco A, Pazienza V, Mazzoccoli G, Vinciguerra M. Redox homeostasis and epigenetics in non-alcoholic fatty liver disease (NAFLD) Curr Pharm Des. 2013;19:2737–2746. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
